Next Science Ltd (NXSCF) Price & Analysis

Q: What was Next Science Ltd’s price range in the past 12 months?

Next Science Ltd lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.

Q: What is Next Science Ltd’s market cap?

Next Science Ltd’s market cap is $29.94M.

Q: When is Next Science Ltd’s upcoming earnings report date?

Next Science Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 13 days.

Q: How were Next Science Ltd’s earnings last quarter?

Next Science Ltd released its earnings results on Aug 28, 2025. The company reported -$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.016.

Q: Is Next Science Ltd overvalued?

According to Wall Street analysts Next Science Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Next Science Ltd pay dividends?

Next Science Ltd does not currently pay dividends.

Q: What is Next Science Ltd’s EPS estimate?

Next Science Ltd’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Next Science Ltd have?

Next Science Ltd has 292,625,370 shares outstanding.

Q: What happened to Next Science Ltd’s price movement after its last earnings report?

Next Science Ltd reported an EPS of -$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Q: Which hedge fund is a major shareholder of Next Science Ltd?

Currently, no hedge funds are holding shares in NXSCF

Compare

8 Followers

NXSCF Stock Chart & Stats

$0.08

<$0.01(13.82%)

At close: Dec 30 4:00 PM EST

$0.08

<$0.01(13.82%)

Day’s Range― - ―

52-Week Range$0.01 - $0.10

Previous CloseN/A

Volume6.25K

Average Volume (3M)2.04K

Market Cap

$29.94M

Enterprise Value$34.31M

Total Cash (Recent Filing)$971.24K

Total Debt (Recent Filing)$5.30M

Price to Earnings (P/E)―

Beta1.25

Next Earnings

Mar 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding292,625,370

10 Day Avg. Volume0

30 Day Avg. Volume2,035

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)6.03

Price to Sales (P/S)0.91

P/FCF Ratio-2.43

Enterprise Value/Market Cap1.15

Enterprise Value/Revenue2.04

Enterprise Value/Gross Profit2.48

Enterprise Value/Ebitda-5.56

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Innovative TechnologyThe focus on innovative solutions for chronic wounds and biofilm infections positions Next Science as a leader in niche healthcare markets, potentially driving long-term growth through unique product offerings.

Proprietary TechnologyThe proprietary Xbio technology provides a competitive edge by disrupting biofilm, enhancing product efficacy, and potentially leading to increased market adoption and licensing opportunities.

Revenue StreamsDiverse revenue streams from direct sales and partnerships enhance market reach and stability, supporting sustainable growth and reducing dependency on single income sources.

Bears Say

Profitability ChallengesPersistent profitability issues with negative margins indicate challenges in covering operational costs, which could hinder long-term financial health and investment capacity.

Negative Cash FlowsOngoing negative cash flows suggest operational inefficiencies and potential liquidity issues, limiting the company's ability to invest in growth and innovation.

High Debt LevelsModerate leverage with high debt levels and negative equity returns can strain financial flexibility, impacting the company's ability to fund future initiatives and manage economic downturns.

Next Science Ltd News

Next Science to Delist from ASX After Shareholder Approval

Next Science Ltd ( ($AU:NXS) ) has shared an update. Next Science Ltd will be removed from the...

8d ago

Next Science Confirms Capital Return and Sets ASX Delisting for 11 February

Next Science Ltd ( ($AU:NXS) ) just unveiled an update. Next Science Limited has confirmed payment of its...

9d ago

Next Science Amends Payment Date for Approved Capital Return

The latest update is out from Next Science Ltd ( ($AU:NXS) ). Next Science Limited has updated its...

17d ago

Next Science Pushes Back Capital Return Payment as It Nears ASX Exit

Next Science Ltd ( ($AU:NXS) ) has shared an announcement. Next Science Limited has updated the market on...

20d ago

Next Science to Return Cash Capital to Shareholders Following Approval

Next Science Ltd ( ($AU:NXS) ) has shared an update. Next Science Limited has announced a cash return...

22d ago

Next Science Investors Back Capital Return and ASX Delisting

Next Science Ltd ( ($AU:NXS) ) just unveiled an update. Shareholders of Next Science Limited have overwhelmingly approved...

22d ago

Next Science Details Cash Position and Capital Return Plan After Asset Sale

Next Science Ltd ( ($AU:NXS) ) just unveiled an update. Next Science has reported a closing cash balance...

22d ago

Next Science Director Harry Thomas Hall IV Steps Down but Retains Shareholding

Next Science Ltd ( ($AU:NXS) ) has issued an announcement. Next Science Limited has announced that director Harry...

1M ago

ASX Suspends Next Science Shares Over Insufficient Operations

Next Science Ltd ( ($AU:NXS) ) has issued an update. ASX has suspended Next Science Limited’s securities from...

2M ago

Next Science Sets Capital Return, Delisting Plan as CEO and CFO Resign

Next Science Ltd ( ($AU:NXS) ) has issued an update. Next Science has called an extraordinary general meeting...

2M ago

NXSCF FAQ

What was Next Science Ltd’s price range in the past 12 months?

Next Science Ltd lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.

What is Next Science Ltd’s market cap?

Next Science Ltd’s market cap is $29.94M.

When is Next Science Ltd’s upcoming earnings report date?

Next Science Ltd’s upcoming earnings report date is Mar 04, 2026 which is in 13 days.

How were Next Science Ltd’s earnings last quarter?

Next Science Ltd released its earnings results on Aug 28, 2025. The company reported -$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.016.

Is Next Science Ltd overvalued?

According to Wall Street analysts Next Science Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Next Science Ltd pay dividends?

Next Science Ltd does not currently pay dividends.

What is Next Science Ltd’s EPS estimate?

Next Science Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Next Science Ltd have?

Next Science Ltd has 292,625,370 shares outstanding.

What happened to Next Science Ltd’s price movement after its last earnings report?

Next Science Ltd reported an EPS of -$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Next Science Ltd?

Currently, no hedge funds are holding shares in NXSCF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Next Science Ltd Stock Smart Score

Neutral

Blogger Sentiment

Bullish

NXSCF Sentiment 70%
Sector Average 70%

Technicals

Fundamentals

Return on Equity

-289.70%

Trailing 12-Months

Asset Growth

-19.99%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Next Science Ltd

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.